| scholarly article | Q13442814 |
| P50 | author | Edgar Ben-Josef | Q37125389 |
| P2093 | author name string | Mary E Davis | |
| Aaron C Spalding | |||
| Benjamin D Zeitlin | |||
| Theodore S Lawrence | |||
| Jacques E Nor | |||
| Kari Wilder-Romans | |||
| P2860 | cites work | Vascular endothelial growth factor receptor-1 promotes migration and invasion in pancreatic carcinoma cell lines | Q24305184 |
| Convergence of multiple signaling cascades at glycogen synthase kinase 3: Edg receptor-mediated phosphorylation and inactivation by lysophosphatidic acid through a protein kinase C-dependent intracellular pathway | Q24537174 | ||
| Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth | Q24561921 | ||
| Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation | Q33868831 | ||
| Protein kinase C inhibitors as novel anticancer drugs | Q34481881 | ||
| Neurotensin phosphorylates GSK-3alpha/beta through the activation of PKC in human colon cancer cells | Q35060343 | ||
| Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression | Q35745301 | ||
| Prognostic significance of angiogenesis in human pancreatic cancer | Q36619020 | ||
| Distinct angiogenic mediators are required for basic fibroblast growth factor- and vascular endothelial growth factor-induced angiogenesis: the role of cytoplasmic tyrosine kinase c-Abl in tumor angiogenesis | Q36631240 | ||
| Protein kinase C beta enhances growth and expression of cyclin D1 in human breast cancer cells | Q40200763 | ||
| Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells | Q40333187 | ||
| LY317615 decreases plasma VEGF levels in human tumor xenograft-bearing mice | Q40620827 | ||
| VEGF-RII influences the prognosis of pancreatic cancer | Q40687210 | ||
| The phosphatidylinositide 3'-kinase/Akt survival pathway is a target for the anticancer and radiosensitizing agent PKC412, an inhibitor of protein kinase C. | Q40766940 | ||
| Differential regulation of glycogen synthase kinase-3 beta by protein kinase C isotypes | Q41607785 | ||
| VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells | Q42815794 | ||
| Angiogenesis in pancreatic carcinoma: thymidine phosphorylase expression in stromal cells and intratumoral microvessel density as independent predictors of overall and relapse-free survival | Q43824334 | ||
| The antiangiogenic agents SU5416 and SU6668 increase the antitumor effects of fractionated irradiation | Q43831996 | ||
| The protein kinase Cbeta-selective inhibitor, Enzastaurin (LY317615.HCl), suppresses signaling through the AKT pathway, induces apoptosis, and suppresses growth of human colon cancer and glioblastoma xenografts | Q46652649 | ||
| Inhibition of protein kinase Cbeta by enzastaurin enhances radiation cytotoxicity in pancreatic cancer | Q46897583 | ||
| SRC family kinase inhibitor SU6656 enhances antiangiogenic effect of irradiation | Q46966099 | ||
| Combined effects of angiostatin and ionizing radiation in antitumour therapy | Q47762838 | ||
| Synergistic antiglioma activity of radiotherapy and enzastaurin | Q48315412 | ||
| De novo expression of vascular endothelial growth factor in human pancreatic cancer: evidence for an autocrine mitogenic loop. | Q52968592 | ||
| High expression of vascular endothelial growth factor predicts early recurrence and poor prognosis after curative resection for ductal adenocarcinoma of the pancreas. | Q53312459 | ||
| Both in vitro and in vivo irradiation are associated with induction of macrophage-derived fibroblast growth factors | Q70909157 | ||
| Mean inactivation dose: a useful concept for intercomparison of human cell survival curves | Q71405944 | ||
| Expression patterns of protein kinase C isoenzymes are characteristically modulated in chronic pancreatitis and pancreatic cancer | Q73146362 | ||
| Pancreatic tumors show high levels of hypoxia | Q73173983 | ||
| Decreasing the apoptotic threshold of tumor cells through protein kinase C inhibition and sphingomyelinase activation increases tumor killing by ionizing radiation | Q73789765 | ||
| Tumor oxygenation in hormone-dependent tumors during vascular endothelial growth factor receptor-2 blockade, hormone ablation, and chemotherapy | Q74256317 | ||
| Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression | Q77554681 | ||
| Expression of two angiogenic factors, vascular endothelial growth factor and platelet-derived endothelial cell growth factor in human pancreatic cancer, and its relationship to angiogenesis | Q77668037 | ||
| Basic fibroblast growth factor induces expression of VEGF receptor KDR through a protein kinase C and p44/p42 mitogen-activated protein kinase-dependent pathway | Q77759145 | ||
| FGF-2 enhances intestinal stem cell survival and its expression is induced after radiation injury | Q77788952 | ||
| Enhancement of tumor radioresponse in vivo by gemcitabine | Q77804784 | ||
| Protein kinase C lies on the signaling pathway for vascular endothelial growth factor-mediated tumor development and angiogenesis | Q78257398 | ||
| Protein kinase B/Akt-dependent phosphorylation of glycogen synthase kinase-3beta in irradiated vascular endothelium | Q82606462 | ||
| P433 | issue | 4 | |
| P921 | main subject | endothelium | Q111140 |
| angiogenesis inhibitor | Q574834 | ||
| P304 | page(s) | 195-201 | |
| P577 | publication date | 2008-12-01 | |
| P1433 | published in | Translational Oncology | Q26839583 |
| P1476 | title | Enzastaurin, an inhibitor of PKCbeta, Enhances Antiangiogenic Effects and Cytotoxicity of Radiation against Endothelial Cells | |
| P478 | volume | 1 |
| Q35546945 | Aberrant methylation of ERBB pathway genes in sporadic colorectal cancer. |
| Q33688600 | Combinatorial inhibition of Plk1 and PKCβ in cancer cells with different p53 status |
| Q37099594 | Combining molecular targeted agents with radiation therapy for malignant gliomas |
| Q39525805 | HDAC inhibitors potentiate the apoptotic effect of enzastaurin in lymphoma cells. |
| Q37258582 | Hyperglycemia regulates RUNX2 activation and cellular wound healing through the aldose reductase polyol pathway |
| Q33915046 | Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growth |
| Q34158974 | Metronomic small molecule inhibitor of Bcl-2 (TW-37) is antiangiogenic and potentiates the antitumor effect of ionizing radiation |
| Q59072618 | Protein Kinase C (PKC) Isozymes and Cancer |
| Q37376611 | Two distinct types of the inhibition of vasculogenesis by different species of charged particles |
Search more.